Health:Further

Vic Gatto and Marcus Whitney cover recent trending topics in healthcare including the Theranos scandal, CommonSpirit’s quarterly report, VC news from WSJ, the PCE index increase, and more.

Vic Gatto and Marcus Whitney explore the recent sale of Pear Therapeutics and what this situation means for the road ahead in the digital therapeutics space. Also included in the discussion is an in-depth look at a recent call to action from Andreessen Horowitz.

Vic Gatto and Marcus Whitney discuss recent developments in healthcare including details around the KKR/Envision bankruptcy situation, the debt ceiling crisis, advancements in AI tech and impact on healthcare, and more.

Emily Evans joins co-hosts Vic Gatto and Marcus Whitney for the discussion in Episode 2. Emily serves as the Health Policy Resident Expert at Hedgeye Risk Management, an independent research firm with a focus on all areas of the economy. Emily describes herself as a “tour guide and translator” for investors and individuals in the healthcare and health policy space.Our discussion explores many trending topics around US Health Policy including home health, CMS, the Chevron Deference, what’s happening at Capitol Hill, and more.

Healthcare VCs and Jumpstart Health Investors co-founders Vic Gatto and Marcus Whitney dive into the history of Health:Further and the purpose of the relaunch. We’re also covering the rise of federal fund rates, market trends, new innovations, what needs to change, and how Health:Further will play a role in keeping the discussion moving forward.